Adult-onset Still’s disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review

go back to reference Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F (2010) Adult-onset Still’s disease. Rheumatol Int 30:855–862. https://doi.org/10.1007/s00296-009-1291-y CrossRefPubMed Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F (2010) Adult-onset Still’s disease. Rheumatol Int 30:855–862. https://​doi.​org/​10.​1007/​s00296-009-1291-y CrossRefPubMed

go back to reference Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed

go back to reference Masson C, Le Loet X, Liote F, Dubost JJ, Boissier MC, Perroux-Goumy L, Bregeon C, Audran M (1996) Comparative study of 6 types of criteria in adult Still’s disease. J Rheumatol 23:495–497PubMed Masson C, Le Loet X, Liote F, Dubost JJ, Boissier MC, Perroux-Goumy L, Bregeon C, Audran M (1996) Comparative study of 6 types of criteria in adult Still’s disease. J Rheumatol 23:495–497PubMed

go back to reference Li X, Qu B, Nie Y, Zhu G, Li W, Mu F (2014) Clinical features of macrophage activation syndrome in the adult northern Chinese population. Lupus 23:785–792. https://doi.org/10.1177/0961203314529467 CrossRefPubMed Li X, Qu B, Nie Y, Zhu G, Li W, Mu F (2014) Clinical features of macrophage activation syndrome in the adult northern Chinese population. Lupus 23:785–792. https://​doi.​org/​10.​1177/​0961203314529467​ CrossRefPubMed

go back to reference Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A (2016) Cytokine profile in adult-onset Still’s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol 169:8–13. https://doi.org/10.1016/j.clim.2016.05.010 CrossRefPubMed Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A (2016) Cytokine profile in adult-onset Still’s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol 169:8–13. https://​doi.​org/​10.​1016/​j.​clim.​2016.​05.​010 CrossRefPubMed

go back to reference Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A (2018) Characteristic elevation of soluble TNF receptor II: i ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Clin Exp Immunol 191:349–355. https://doi.org/10.1111/cei.13026 CrossRefPubMed Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A (2018) Characteristic elevation of soluble TNF receptor II: i ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Clin Exp Immunol 191:349–355. https://​doi.​org/​10.​1111/​cei.​13026 CrossRefPubMed

go back to reference Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ, Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society (2016) 2016 Classification Criteria for Macrophage Activation Syndrome complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Ann Rheum Dis 75:481–489. https://doi.org/10.1002/art.39332 CrossRefPubMed Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ, Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society (2016) 2016 Classification Criteria for Macrophage Activation Syndrome complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Ann Rheum Dis 75:481–489. https://​doi.​org/​10.​1002/​art.​39332 CrossRefPubMed

go back to reference Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, Toma T, Ohta K, Kasahara Y, Yachie A (2010) Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) 49:1645–1653. https://doi.org/10.1093/rheumatology/keg133 CrossRef Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, Toma T, Ohta K, Kasahara Y, Yachie A (2010) Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) 49:1645–1653. https://​doi.​org/​10.​1093/​rheumatology/​keg133 CrossRef

go back to reference Wu CY, Yang HY, Yao TC, Liu SH, Huang JL (2016) Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients. Medicine (Baltimore). 95:e5037. https://doi.org/10.1136/lupus-2017-000215.334 CrossRefPubMedPubMedCentral Wu CY, Yang HY, Yao TC, Liu SH, Huang JL (2016) Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients. Medicine (Baltimore). 95:e5037. https://​doi.​org/​10.​1136/​lupus-2017-000215.​334 CrossRefPubMedPubMedCentral

go back to reference Saiki O, Uda H, Nishimoto N, Miwa T, Mima T, Ogawara T, Azuma N, Katada Y, Sawaki J, Tsutsui H, Matsui K, Maeda A, Nakanishi K (2004) Adult Still’s disease reflects a Th2 rather than a Th1 cytokine profile. Clin Immunol 112:120–125. https://doi.org/10.1016/j.clim.2004.03.023 CrossRefPubMed Saiki O, Uda H, Nishimoto N, Miwa T, Mima T, Ogawara T, Azuma N, Katada Y, Sawaki J, Tsutsui H, Matsui K, Maeda A, Nakanishi K (2004) Adult Still’s disease reflects a Th2 rather than a Th1 cytokine profile. Clin Immunol 112:120–125. https://​doi.​org/​10.​1016/​j.​clim.​2004.​03.​023 CrossRefPubMed

go back to reference Chen DY, Lan JL, Lin FJ, Hsieh TY (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s disease. J Rheumatol 31:2189–2198PubMed Chen DY, Lan JL, Lin FJ, Hsieh TY (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s disease. J Rheumatol 31:2189–2198PubMed

go back to reference Kasama T, Furuya H, Yanai R, Ohtsuka K, Takahashi R, Yajima N, Miwa Y, Kobayashi K (2012) Correlation of serum CX3CL1 level with disease activity in adult-onset Still’s disease and significant involvement in hemophagocytic syndrome. Clin Rheumatol 31:853–860. https://doi.org/10.1007/s10067-012-1952-1 CrossRefPubMed Kasama T, Furuya H, Yanai R, Ohtsuka K, Takahashi R, Yajima N, Miwa Y, Kobayashi K (2012) Correlation of serum CX3CL1 level with disease activity in adult-onset Still’s disease and significant involvement in hemophagocytic syndrome. Clin Rheumatol 31:853–860. https://​doi.​org/​10.​1007/​s10067-012-1952-1 CrossRefPubMed

go back to reference Jamilloux Y, Gerfaud-Valentin M, Henry T, Sève P (2014) Treatment of adult-onset Still’s disease: a review. Ther Clin Risk Manag 11:33–43. https://doi.org/10.2147/TCRM.S64951 CrossRefPubMedPubMedCentral Jamilloux Y, Gerfaud-Valentin M, Henry T, Sève P (2014) Treatment of adult-onset Still’s disease: a review. Ther Clin Risk Manag 11:33–43. https://​doi.​org/​10.​2147/​TCRM.​S64951 CrossRefPubMedPubMedCentral

go back to reference Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Sève P (2015) Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart. Immunol Res 61:53–62. https://doi.org/10.1007/s12026-014-8561-9 CrossRefPubMed Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Sève P (2015) Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart. Immunol Res 61:53–62. https://​doi.​org/​10.​1007/​s12026-014-8561-9 CrossRefPubMed

go back to reference de Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147. https://doi.org/10.1007/s10067-2105-2 CrossRefPubMed de Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147. https://​doi.​org/​10.​1007/​s10067-2105-2 CrossRefPubMed

go back to reference Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548–552CrossRef Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548–552CrossRef

go back to reference Seo JY, Suh CH, Jung JY, Kim AR, Yang JW, Kim HA (2017) The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still’s disease: a STROBE-compliant retrospective observational analysis. Medicine (Baltimore). 96:e7546. https://doi.org/10.1097/MD.0000000000007546 CrossRefPubMedPubMedCentral Seo JY, Suh CH, Jung JY, Kim AR, Yang JW, Kim HA (2017) The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still’s disease: a STROBE-compliant retrospective observational analysis. Medicine (Baltimore). 96:e7546. https://​doi.​org/​10.​1097/​MD.​0000000000007546​ CrossRefPubMedPubMedCentral

go back to reference Jung KH, Kim JJ, Lee JS, Park W, Kim TH, Jun JB, Yoo DH (2014) Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease. Scand J Rheumatol 43:162–169. https://doi.org/10.3109/03009742.2013.824023 CrossRefPubMed Jung KH, Kim JJ, Lee JS, Park W, Kim TH, Jun JB, Yoo DH (2014) Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease. Scand J Rheumatol 43:162–169. https://​doi.​org/​10.​3109/​03009742.​2013.​824023 CrossRefPubMed